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The analysis of the 100000 x g supernatant fraction of cultured rat glomerular mesangial cells with DEAE- 
cellulose ion-exchange chromatography revealed a large peak showing the activity of a protein kinase (pro- 
tein kinase C) which depended on phospholipid and diolein as well as Caz+. Furthermore, it was shown 
that angiotensin II (AH) ( 10m6 M) induced rapid hydrolysis of phosphatidylinositol4,Sbisphosphate, lead- 
ing to production of diacylglycerol rich in arachidonic acid, in the cultured rat mesangial cells. These results 
suggest that activation of protein kinase C resulting from enhancement of phosphoinositide metabolism 
may be important as an intracellular regulatory mechanism of AI1 upon cultured mesangial cells. 
(Mesangial celI) Angiotensin II Protein kinase C Phosphoinositide metabolism Second messenger 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The glomerula mesangial cell is a target for AI1 
[ 11. The contraction and prostaglandin production 
by AI1 are important in the regulation of 
glomerular ultrafiltration process. However, the 
intracellular mechanism of AI1 actions on these 
cells has not yet been clarified and cyclic 
nucleotides do not appear to play important roles 
[2]. Protein kinase C, a novel type of protein 
kinase, whose activity depends not only on Ca2+ 
but also on phospholipid and unsaturated DG, one 
of the products of phosphoinositide breakdown, 
has attracted attention as a key enzyme in the 
regulation of various cell functions [3]. 
Using cultured rat mesangial cells, this experi- 
ment was designed to examine the presence of pro- 
tein kinase C and a possible relation of enhanced 
turnover of inositol phospholipids by AII. 
Abbreviations: AII, angiotensin II; PIP2, phosphatidyl- 
inositol 4,Sbisphosphate; PIP, phosphatidylinositol 
4-monophosphate; PI, phosphatidylinositol; PA, phos- 
phatidic acid; PC, phosphatidylcholine; PE, phosphati- 
dylethanolamine; DC, diacylglycerol 
A mixture of phospholipid, calf thymus Hl 
histone and [Y-~~P]ATP were prepared as in [4-61. 
Synthetic diolein was purchased from Nakarai 
Chemicals. Type I collagenase and soybean trypsin 
inhibitor were obtained from Sigma. AI1 (syn- 
thetic, human form) was obtained from Peptide 
Institute, Protein Research Foundation. DEAE- 
cellulose (DE-52) was obtained from Whatman. 
Carrier-free [32P]orthophosphate was obtained 
from Japan Atomic Energy Research Institute. 
[5,6,8,9,11,12,14,15-3H]Arachidonic acid was ob- 
tained from Amersham. 
2.1. Culture and preparation of rat mesangial cells 
The culture of glomerular mesangial cells was 
performed as in [7] with some modifications. 
Briefly, glomeruli were isolated from male 
Sprague-Dawley rats (70-90 g body wt) by con- 
secutive sieving with 3 different meshes (120, 280 
and 53 pm). The glomeruli were cultured at 37°C 
in a 95% air and 5% CO2 environment, using the 
following tissue culture medium: 5 ml RPM1 1640 
medium supplemented with 20% decomplemented 
fetal calf serum (Irvine Scientific) and 1 pg/ml in- 
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sulin. Mesangial growth predominated by day 21 
of the primary culture when the subculture was 
performed. The second subcultured cells were 
employed for this experiment to confirm the 
following criteria which have already been 
reported [2,8-131: (i) the cells had large bundles of 
intracellular microfilaments; (ii) the intracellular 
fibrils of the cells were strongly stained by FITC- 
labelled heavy meromyosin, indicating the abun- 
dance of actin; (iii) the intracellular fibrils, cell 
membranes and extracellular materials of the cells 
were strongly stained by FITC-antifibronectin an- 
tibody; (iv) unlike monocytes, the cells did not 
show binding capacities for Fc or C3b and 
phagocytic activities for horseradish peroxidase or 
sensitized sheep red blood cells; (v) the cells had 
receptors for AII; (vi) the cells contracted in 
response to AII. The cells were treated with col- 
lagenase and trypsin inhibitor as in [13], and then 
the cell suspension was prepared by gentle 
pipetting. 
2.2. Assay for protein kinase C 
Protein kinase C was assayed by measuring the 
32P incorporation from [y-32P]ATP into calf 
thymus Hl histone in the presence of Ca*+, 
phospholipid and diolein. The complete reaction 
mixture (0.25 ml) contained 5pmol Tris-HCl at 
pH 7.5, 1.25 pmol magnesium acetate, 5Opg Hl 
histone, 2.5 nmol [y-32P]ATP (1.2 x 10’ cpm/ 
nmol), 0.25 pmol CaC12, 20 pg phospholipid, 
0.6 pg diolein and enzyme solution. Incubation 
was carried out for 5 min at 30°C. The reaction 
was stopped by the addition of 25% trichloroacetic 
acid and acid-precipitable radioactivity was deter- 
mined as in [3]. The protein concentration was 
determined as in [14] with bovine serum albumin 
as a standard. 
2.3. Assay for phospholipid labelling stimulated 
by AII 
Cultured cell medium was replaced in Hepes- 
buffered (30 mM, pH 7.4) Hanks’ solution. For 
[3H]arachidonic acid labelling, the cells were prein- 
cubated in Hepes-buffered Hanks’ solution con- 
taining 0.2% fatty acid-free bovine serum albumin 
(BSA) and [3H]arachidonic acid (about 
2.5 ,&i/0.5 ml per 5 x lo5 cells). After 120 min 
preincubation, the cells were washed 3 times with 
the previous buffer. 10 min after labelling, the ex- 
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periments were carried out. The cells were in- 
cubated for each indicated time (O-l min) with 
AI1 (10e6 M). Phospholipids were extracted as in 
[15]. Separation was done by silica gel thin-layer 
chromatography as in [16,17]. The spots cor- 
responding to phospholipids such as PIP*, PIP, PI 
and DG were scraped into vials and dissolved 
10 ml ACS-II (Amersham). The radioactivity was 
determined using a liquid scintillation counter 
(Aloca 713). 
3. RESULTS AND DISCUSSION 
When the crude supernatant was fractionated on 
DEAE-cellulose ion-exchange chromatography, a 
large asymmetrical peak showing the enzyme ac- 
tivity appeared in fractions 7-l 1 (fig. 1). Since the 
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Fig. 1. Analysis of protein kinase C in cultured mesangial 
cells on DEAE-cellulose ion-exchange chromatography. 
About 1.8 x lo6 cells were disrupted by sonication with 
a Kontes model K881440 sonifier, for 2 min at 4°C in 
1 ml of 20 mM Tris-HCl buffer at pH 7.5, containing 
0.25 M sucrose, 2 mM EDTA and 5 mM EGTA. The 
sonicate was centrifuged for 60 min at 100000 x g and 
the supernatant utilized for experiments. An aliquot 
(0.5 ml) of the 100000 x g supernatant was applied to a 
DE-52 column equilibrated with 20 mM Tris-HCl, pH 
7.5, containing 50 mM 2-mercaptoethanol, 1 mM 
EDTA and 1 mM EGTA. After the column was washed 
with 4 ml equilibrium buffer, protein kinase C was 
eluted by a 20 ml linear concentration gradient of NaCl 
(O-O.3 M) in equilibrium buffer. Fractions of 0.38 ml 
each were collected. A 50 ~1 aliquot of each fraction was 
employed for protein kinase C assay: (M) with 
Ca2+, phospholipid and diolein; (O---O) with 0.5 mM 
EGTA; (- - -) electroconductance (mS). 
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protein kinase activity of peak fraction 8 depended 
on the simultaneous presence of 3 cofactors, that 
were Ca2+, phospholipid and diolein (table l), this 
peak fraction was identified as protein kinase C. 
DG, which is derived from the breakdown of 
phosphoinositides, is the most important 
modulator of protein kinase C activity [18,19]. 
Recently, Schlondorff et al. [20] showed that AI1 
caused a decrease of [‘4C]arachidonic acid-labelled 
PI and an increase of [14C]arachidonic acid- 
labelled DC at 2 or 5 min in cultured rat mesangial 
cells. However, fig.2 shows a decrease of 
[3H]arachidonic acid-labelled PIP2 and an increase 
of [3H]arachidonic acid-labelled at 30 or 60 s of in- 
cubation with AI1 (10e6 M). The data in fig.2 in- 
dicate that PIP2 is rapidly hydrolysed within 30 s 
with a resultant production of DC rich in 
arachidonic acid, an activator of protein kinase C, 
in response to AI1 (10m6 M) addition in cultured 
mesangial cells. The change of [3H]arachidonic 
acid-labelled PI was hardly shown within 1 min. 
Fig.3 shows the dose-related effect of AI1 on DG 
production after 30 s incubation. In addition, we 
observed that AI1 (10m6 M) stimulated 32P incor- 
poration into PA and PI but not into PC and PE 
(O-30 min) (not shown). These results indicate that 
AI1 enhances phosphoinositide turnover, primarily 
by inducing PIP2 hydrolysis, leading to the forma- 
tion of DG, in cultured rat mesangial cells. 
The formation of DG derived from the 
breakdown of phosphoinositides with a resultant 
activation of protein kinase C, leading to 
phosphorylation of 40 kDa protein, is a key step in 
the thrombin-induced release of serotonin in 
Table 1 
Activation of protein kinase C of cultured mesangial 
cells by Ca*+, phospholipid and diolein 
Assay system Protein kinase 
activity (cpm) 
Complete system 8760 
- Ca*+ - phospholipid - diolein 
+ 0.5 mM EGTA 1999 
_ Ca2+ + 0.5 mM EGTA 1279 
- phospholipid - diolein 1016 
A 50~1 aliquot of fraction 8 in fig.1 was employed for 
protein kinase assay. For the complete system, 1 mM 
CaC12, 20/g phospholipid and 0.6rg diolein were 
employed 
Tine ( se= I 
Fig.2. Effect of AI1 on phosphoinositide breakdown in 
cultured mesangial cells. Cultured mesangial cells were 
labelled with [3H]arachidonic acid and then stimulated 
with AI1 (10m6 M) for the indicated times. (M) 
PIPI, (H) PIP, (M) PI, (M) DG. The 
results are means + SE for triplicate experiments. ** p < 
0.01, * p < 0.05 vs control. 
human platelets [21-231. In this experiment, 
however, we have not yet determined the substrate 
for protein kinase C which coupled with the activa- 
tion of this enzyme to the biological function in 
mesangial cells. A recent report has shown that 
myosin light chain which, when phosphorylated, 
regulates the contraction of smooth muscle and 
non-smooth muscle cells, serves as a substrate for 
protein kinase C [24] as well as for 
Ca2+ . calmodulin-dependent myosin light chain 
kinase [25]. Therefore, phosphorylation of myosin 
light chain by protein kinase C may regulate 
mesangial cell contraction induced by AII. 
An initial event of enhancing turnover of in- 
ositol phospholipids by AI1 appears to be responsi- 
ble for protein kinase C activation in mesangial 
cells and a regulatory role of this activation in AI1 
actions via this route is suggestive. 
ACKNOWLEDGEMENTS 
We thank Professor Yasutomi Nishizuka, 
157 
Volume 192. number 1 FEBS LETTERS November 1985 
a 
i 
T 
OL 
o// 10 1 a 6 
-Lay ( Xng1otens1n II Concentration ) ( .\I ) 
Fig.3. Effect of various concentrations of AI1 on the 
formation of DC. Cultured mesangial cells were labelled 
with [3H]arachidonic acid and then stimulated with AI1 
(lO_‘O, lo-’ and 10m6 M) for 30 s. The results are 
means -t SE for triplicate experiments. * p < 0.05 vs 
control. 
Department of Biochemistry, Kobe University 
School of Medicine, for his valuable advice and en- 
couragement. This work was partly supported by 
Grant-in-aid for Scientific Research (A), the Basic 
and Clinical Research on the Significance of 
Mesangium in the Onset and the Progression of 
Glomerulonephritis from the Ministry of Educa- 
tion, Science and Culture, Japan and by Grant-in- 
aid for Intractable Disease from the Ministry of 
Health and Welfare, Japan. 
REFERENCES 
[II 
121 
158 
Scharschmidt, L.A. and Dunn, M.J. (1983) J. Clin. 
Invest. 71, 175661764. 
Ausiello, D.A., Kreisberg, J.I., Roy, C. and 
Karnovsky, M.J. (1980) J. CIin. Invest. 65, 
754-760. 
131 
I41 
[51 
KY 
[71 
PI 
191 
[lOI 
IllI 
u21 
[I31 
1141 
(151 
1161 
1171 
[I81 
[I91 
[W 
WI 
WI 
[231 
v41 
v51 
Takai, Y., Kishimoto, A., Iwasa, Y., Kawahara, 
Y., Mori, T. and Nisi rzuka, Y. (1979) J. Biol. 
Chem. 254, 3692-3695. 
Castagna, M., Takai, Y., Kaibuchi, K., Sane, K., 
Kikkawa, U. and Nishizuka, Y. (1982) J. Biol. 
Chem. 257, 7847-785 1. 
Hashimoto, E., Takeda, M., Nishizuka, Y., 
Hamana, K. and Iwai, K. (1976) J. Biol. Chem. 
25 1, 6287-6293. 
Glynn, I.M. and Chappell, J.B. (1964) Biochem. J. 
90, 147-149. 
Foidart, J.B., Dechenne, CA., Mahieu, P., 
Creutz, C.E. and De Mey, J. (1979) Invest. Cell 
Pathol. 2, 15-26. 
Latta, H. (1973) in: Renal Physiology (Orloff, J. 
and Berliner, R.W. eds) Handbook of Physiology, 
section 8, pp. l-29, American Physiological 
Society, Washington, DC. 
Linder, E., Miettinen, A. and Toernroth, T. (1980) 
Lab. Invest. 42, 70-75. 
Kreisberg, J.I. and Karnovsky, M.J. (1978) Kidney 
Int. 14, 21-30. 
Kreisberg, J.I. and Karnovski, M.J. (1983) Kidney 
Int. 23, 439-447. 
Mahieu, P.R., Foidart, J.B., Dubois, C.H., 
Dechenne, C.A. and De Heneffe, J. (1980) Invest. 
Cell Pathol. 3, 121-128. 
Foidart, J., Sraer, J., Delarue, F., Mahieu, P. and 
Ardaillou, R. (1980) FEBS Lett. 121, 333-339. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
Billah, M.M. and Lapetina, E.G. (1982) J. Biol. 
Chem. 257, 5196-5200. 
Volpi, M., Yassin, R., Nacchache, P.H. and 
Sha’afi, R.I. (1983) Biochem. Biophys. Res. Com- 
mun. 112, 957-964. 
Rittenhouse-Simmons, S. (1979) J. Clin. Invest. 63, 
580-587. 
Kishimoto, A., Takai, Y., Mori, T., Kikkawa, U. 
and Nishizuka, Y. (1980) J. Biol. Chem. 255, 
2273-2276. 
Kaibuchi, K., Sane, K., Hoshijima, M., Takai, Y. 
and Nishizuka, Y. (1982) Cell Calcium 3, 323-335. 
Schlondorff, D., Perez, J. and Satriano, J.A. 
(1985) Am. J. Physiol. 248, C119-C126. 
Kawahara, Y., Takai, Y., Minakuchi, R., Sano, K. 
and Nishizuka, Y. (1980) J. Biochem. 88,913-916. 
Kawahara, Y., Takai, Y., Minakuchi, R., Sane, K. 
and Nishizuka, Y. (1980) Biochem. Biophys. Res. 
Commun. 97, 309-317. 
Takai, Y., Kaibuchi, K., Matsubara, T. and 
Nishizuka, Y. (1981) Biochem. Biophys. Res. Com- 
mun. 101, 61-67. 
Endo, T., Naka, M. and Hidaka, H. (1982) Bio- 
them. Biophys. Res. Commun. 105, 942-948. 
Murphy, R.A. (1982) Hypertension 4, 11-3-11-7. 
